India keeps markets guessing ahead of three key RBI MPC appointments

India keeps markets guessing ahead of three key RBI MPC appointments


India’s central bank watchers are getting anxious about who will decide interest rates. Image: Bloomberg

By Anup Roy

India’s central bank watchers are getting anxious about who will decide interest rates in two week’s time, a crucial meeting as a wave of global easing kicks off.


The contracts of three external members of the Reserve Bank of India’s monetary policy committee will expire on Oct. 4, just days before the MPC is expected to meet and make its rate decision on Oct. 9. A government-appointed selection panel hasn’t disclosed who the likely candidates are or when they will release the names of the new MPC members.

Click here to connect with us on WhatsApp


A delay in the appointments risks a repeat of 2020, when the RBI had to postpone its rate decision because the new committee members hadn’t been appointed in time. Looming in the background is also uncertainty over who will lead the RBI from next year, with the contracts of both Governor Shaktikanta Das and his deputy in charge of monetary policy, Michael Patra, coming to an end in coming months. 

 


“Extensions and reappointments should be concluded and announced well ahead avoiding last minute delays. Unwarranted suspense in critical appointments is unsettling and distracting,” said Shubhada M Rao, founder of QuantEco Research, based in Mumbai. “This becomes relevant especially for the financial markets that seek signals around policy continuity,” she said. 


The RBI’s policy committee is made up of three external members — usually well-known economists from the academic or finance worlds — and three RBI officials, comprising the governor, the deputy governor in charge of the monetary policy, and another official, typically the executive director of the monetary policy department.  


Das’s contract — already extended once by three years — comes to an end on Dec. 9 and Patra finishes his term on Jan. 14. Neither the government nor the RBI have signaled if they will remain in their posts.


MPC Doves


The external MPC members who end their terms next month have been more dovish than their RBI counterparts in recent rate meetings. Both Goyal and Varma voted for rate cuts in the past two meetings. Bhide raised concerns about the impact of high rates on economic growth, even though he voted in line with RBI officials. 


Analysts say India should follow other central banks in having a more transparent process in selecting key candidates. At the Bank of England, for example, four external MPC members are appointed through an open and public process where the applicants are known before the selection is made. 


“Why would there be so much of secrecy” about the appointments at the RBI, asked Amol Agrawal, who teaches economics at Ahmedabad University. “They are external members, they cannot be appointed like insiders. What is the big deal in not naming the members, and not following an open, transparent process?”


A selection panel — led by Das, Cabinet Secretary T.V. Somanathan and Economic Affairs Secretary Ajay Seth — chooses the external MPC members. Prime Minister Narendra Modi’s office has final sign-off on the positions.  


The RBI and prime minister’s office didn’t immediately respond to emails seeking further information.


Appointments of key RBI officials are typically made ahead of time, aside from the 2020 debacle, which was partly due to disruptions over the pandemic period.

“While clarity is always welcome, I think as long as candidates are being vetted properly and being announced with a reasonable window, we do not feel there is any material impact on decision making,” said Rahul Bajoria, an economist at Bank of America Corp.    

Charts


Before the MPC was appointed in 2016, interest rates were decided by the governor alone. While policymaking is more consensus-based now, the governor still has veto power to break a deadlock in the six-member MPC. 


Change in the leadership of the RBI can bring sweeping monetary policy shifts. Urjit Patel, who was RBI governor before Das took over in December 2018, was a policy hawk, rejecting calls to cut interest rates even when inflation tumbled to a record low of 1.46 per cent in June 2017. In Das’s first MPC meeting in February 2019, he promptly cut rates in a surprise move.  


Das is now facing calls to cut interest rates as global central banks pivot and the economy shows signs of moderating. The governor has repeatedly said he’s not considering a cut yet and wants to see inflation easing to the 4 per cent target and staying there.


If the new MPC members are appointed before the October MPC meeting, analysts don’t expect they will have enough time to acquaint themselves with the issues to call for a rate cut. Economists surveyed by Bloomberg predict the RBI will likely ease in December.


“The MPC is unlikely to make a sharp pivot in October as the internal RBI members remain the same for now and Governor Das has the casting vote in case of any tie,” said Shumita Sharma Deveshwar, an economist at GlobalData.TS Lombard. 

First Published: Sep 27 2024 | 10:15 AM IST



Source link

UBS fears slowdown in India, US pharma markets; gives 'Sell' on 4 stocks

UBS fears slowdown in India, US pharma markets; gives 'Sell' on 4 stocks



Global brokerage UBS has raised concerns about weakening trends in the Indian and the US pharmaceutical markets. In its recent coverage initiation report, UBS said the pace of a decline in the US generic market is likely to worsen, while the growth of India pharma market has been slowing and recent trends of sharp increase in unbranded generics is a concern.

“These two markets account for 70-80 per cent of sector profits and would imply lower growth. The balance sheets are healthy to invest for new growth drivers but growth normalisation may take time,” UBS said in its report titled ‘India Pharmaceutical Sector: Trends weakening in India, US’.

Click here to connect with us on WhatsApp

 


UBS on India, US Pharma market


As per analysts at UBS, the Street is under-appreciating growth slowdown in both India and the US. The Indian pharmaceutical market is slowing down due to a sharp increase in unbranded generics. The increase is caused because of the scale-up of the government’s Jan Aushadhi (JA) drug stores (5 per cent of the market) and trade generics (over 20 per cent of the market).


“Manufacturers’ profitability in unbranded generic products is less than half that of branded generics and therefore increasing penetration of unbranded generics is a concern,” UBS said.


Additionally, a sharp increase in JA stores could impact 1-2 per cent of the annual growth of the Indian market on a base of 8 per cent CAGR.


Meanwhile, some structural negatives in the US markets that are causing concerns are concentrated channels, potential negative surprises from Food and Drugs Administration (FDA) inspections, a large abbreviated new drug application (ANDA) backlog of 5 times annual filings, and high penetration (92% of prescriptions are generics).


“The market is focused on the price erosion cycle for mature molecules, but they account for only 20 per cent of US profits and the more important trend is ANDA approval rate,” UBS said.


UBS Buy, Sell calls on Indian pharma stocks


The global brokerage has initiated coverage on Zydus Lifesciences and Dr Reddy’s Laboratories with a ‘Sell’ call due to street overestimating core margins.


For Zydus Lifesciences the target is set at Rs 850 and for Dr Reddy’s Labs at Rs 5,700 per share.


Likewise, UBS has given a ‘Sell’ call on Aurobindo Pharma with targets of Rs 1,333 per share. Analysts reckon the valuations are high despite low growth and low Return on Capital Employed (RoCE).


For Lupin too, the brokerage has given a ‘Sell’ call with a target of Rs 2,250 per share owing to the company already pricing one-off benefits in FY25 and FY26.


Conversely, It has given a ‘Buy’ rating on Sun Pharma and Cipla with a target of Rs 2,450 and Rs 2,060 respectively.


For Sun Pharma, UBS expects patented molecules to double in revenues over 4 years and margins to expand by 650 basis points (bps) for an overall earnings per share (EPS) compound annual growth rate (CAGR) of 19 per cent.


Similarly, the brokerage likes Cipla as the US upside from the injectable and respiratory portfolio is not yet fully factored in.

First Published: Sep 27 2024 | 9:08 AM IST



Source link

Stock market live updates today sensex Nifty NSE BSE live blog Sept 27 it stocks Adani KRN Heat IPO: Stock Market Today

Stock market live updates today sensex Nifty NSE BSE live blog Sept 27 it stocks Adani KRN Heat IPO: Stock Market Today



Stock Market LIVE Updates, Friday, September 27, 2024: Indian equity benchmark indices were poised for a higher open on Friday, tracking overnight gains in the US and a positive trend in Asian markets, as indicated by GIFT Nifty futures.




At 8:35 AM, GIFT Nifty futures were trading at 26,350, around 40 points ahead of Nifty futures’ last close.




Meanwhile, Indian benchmark BSE Sensex rallied 666 points to close at a fresh high on Thursday fuelled by a rally in auto and banking stocks.




The BSE Sensex jumped 0.78 per cent to settle at 85,836.12 on the monthly derivatives expiry day. The Nifty 50 index closed at 26,216, up 212 points or 0.8 per cent.




The total market capitalisation of BSE listed stocks rose by Rs 1.9 trillion, to end the session at Rs 477 trillion. The Nifty finished with gains on all sessions, barring six, this month.




The latest gains were underpinned by a rally in auto majors after reports suggested Karnataka would offer incentives to clean mobility, including a steep tax cut for hybrid cars.




Most of Sensex’s gains were contributed by Mahindra & Mahindra, which rose 2.9 per cent, Maruti, which gained 4.8 per cent, and Tata Motors that revved by 3.08 per cent.




That apart, most markets in the Asia-Pacific region advanced, led by gains in Chinese stocks. In Hong Kong, the Hang Seng index was up 2.43 per cent, while the Shanghai Composite was up 1.3 per cent.




Japan’s Nikkei 225 rose 0.33 per cent, while the broader Topix index saw a slight decline of 0.23 per cent.




In South Korea, the Kospi slipped 0.07 per cent, while the small-cap Kosdaq fell 0.15 per cent. Conversely, Australia’s S&P/ASX 200 was up 0.06 per cent.




That apart, global stock indexes reached record highs on Thursday after chipmaker Micron Technology’s upbeat forecast, while oil dropped on a media report that Saudi Arabia plans to dump its unofficial crude price target of $100 a barrel.




Silver rose to its highest level in nearly 12 years, with interest rate cuts by major central banks lifting investment interest in precious metals.




The S&P 500 registered an all-time closing high, as did the pan-European STOXX 600 index. MSCI’s global stock index hit an intraday record.




Micron’s forecast late on Wednesday bolstered optimism about demand for chips used for artificial intelligence computing. 




US Treasury yields edged higher after strong data, including an unexpected drop in weekly US jobless claims, led traders to cut bets that the Federal Reserve will make another 50-basis point cut at its November meeting.




Other US reports showed corporate profits increased at a more robust pace than initially thought in the second quarter, while gross domestic product grew at an unrevised 3 per cent.




Investors anxiously await Friday’s release of the core personal consumption expenditures (PCE) price index, the Fed’s preferred measure of inflation.




The Dow Jones Industrial Average rose 260.36 points, or 0.62 per cent, to 42,175.11, the S&P 500 increased 23.11 points, or 0.40 per cent, to 5,745.37 and the Nasdaq Composite was 108.09 points, or 0.60 per cent, higher at 18,190.29.




European shares followed China’s market higher. The pan-European STOXX 600 index closed 1.3 per cent higher at 525.61 points, an all-time closing high. 




MSCI’s gauge of stocks across the globe rose 7.08 points, or 0.84 per cent, to 850.69 and hit a record during trading.




An official readout from a meeting of China’s politburo said Beijing would deploy “necessary fiscal spending” to meet this year’s economic growth target of roughly 5 per cent, acknowledging new problems and raising market expectations for fresh stimulus on top of measures announced this week.




Reuters reported separately that China plans to issue special sovereign bonds worth about 2 trillion yuan ($284 billion) this year, primarily to stimulate consumption.




In commodities, spot silver was up 0.6 per cent at $32.03 per ounce as of Thursday afternoon, having hit its highest since December 2012 at $32.71. Spot gold was up 0.5 per cent at $2,670.52 per ounce, having hit a record high of $2,685.42 earlier in the day.




Crude prices in the US fell $2.02 to settle at $67.67 a barrel and Brent dropped $1.86 to settle at $71.60.




In Treasuries, benchmark 10-year yields rose 0.8 basis points to 3.789 per cent and earlier reached 3.821 per cent, the highest since Sept. 4.




Traders are now pricing in a 51 per cent probability that the Fed will cut rates by 50 basis points at the conclusion of its Nov. 6-7 meeting, down from 63 per cent before the most recent data, according to the CME Group’s FedWatch Tool.




The dollar index, which measures the greenback against a basket of currencies including the yen and the euro, fell 0.42 per cent to 100.52, on track for its sixth drop in seven sessions, after rising as high as 100.95 earlier in the day. 



Source link

Stocks To Watch: HDFC, IT stocks, Torrent Pharma, Ola Electric, Adani Green

Stocks To Watch: HDFC, IT stocks, Torrent Pharma, Ola Electric, Adani Green



Stocks to Watch, Friday, September 27, 2024: Indian equity benchmark indices looked set for a higher open on Friday, following overnight gains in the US and higher Asian markets. The same was indicated by GIFT Nifty futures.




At 7:10 AM, GIFT Nifty futures were trading at 26,349, around 40 points ahead of Nifty futures’ last close. 

Click here to connect with us on WhatsApp




Markets in the Asia-Pacific region mostly climbed on Friday, on the back of gains in Chinese stocks. 




In Hong Kong, futures for the Hang Seng index stood at 20,575, suggesting a potential opening gain of over 3 per cent compared to the previous close of 19,924.58.

 




Tokyo’s headline inflation rate eased to 2.2 per cent, down from 2.6 per cent in August, while the core inflation rate, excluding fresh food prices, matched expectations at 2 per cent, decreasing from 2.4 per cent. 




In response to these figures, Japan’s Nikkei 225 rose 0.52 per cent, though the broader Topix index fell 0.23 per cent. 




South Korea’s Kospi slipped 0.18 per cent, and the small-cap Kosdaq declined 0.15 per cent. Meanwhile, Australia’s S&P/ASX 200 gained 0.25 per cent, closing in on its all-time high of 8,246.2.




Overnight in the US, all three major indexes advanced, with the S&P 500 reaching a new record of 5,745.37. The Nasdaq Composite rose 0.60 per cent, while the Dow Jones Industrial Average climbed 0.62 per cent. 




Meanwhile, here are a few stocks likely to be in focus today: 


Fortis Healthcare: IHH Healthcare’s Group CEO, Prem Kumar Nair, announced that the company has no immediate plans to list its diagnostics arm, Agilus Diagnostics, despite its significance to the overall business. Fortis acquired a 31 per cent stake held by private equity players in Agilus Diagnostics for Rs 1780 crore, a deal that valued Agilus at Rs 5,700 crore. 




HDFC Bank: The bank has sold a housing loan portfolio worth about Rs 60 billion ($717 million) to several state-controlled banks as part of its strategy to reduce credit load amid regulatory pressures. Additionally, the bank offloaded a pool of car loans worth Rs 90.6 billion through securitised pass-through certificates. These moves are aimed at improving its credit-deposit ratio, which has been under scrutiny following its merger with Housing Development Finance Corp.




Reliance Infrastructure: Reliance Infrastructure is considering raising long-term capital through various means, including equity shares and convertible securities. A board meeting is scheduled for October 1 to discuss the details. Recently, the company approved a plan to raise over Rs 6,000 crore, aimed at business expansion and meeting long-term working capital needs.




IT stocks: With Accenture raising its revenue guidance for FY25 to 3–6 per cent, exceeding its previous guidance, IT stocks in India would be in focus today. Despite a challenging FY24, the company reported a revenue increase to $64.9 billion. The firm is experiencing strong momentum in generative AI, with $3 billion in new bookings. 




NTPC: NTPC Green Energy, the renewable energy arm of NTPC, has highlighted potential risks in its IPO filing, particularly regarding restrictions on imports from China, a key supplier for solar and wind equipment. The company imported Rs 1,271 crore worth of equipment from China in FY24, and such trade restrictions could impact its business operations.




Hindustan Copper: HCL is working on expansion projects to increase its mine production capacity to 12.2 million tonnes per annum (MTPA). The company reported a 13 per cent rise in ore production in FY24 and is transitioning from open cast to underground mining, with significant capacity increases planned for its various sites.




Maruti Suzuki India: Hyundai Motor India, preparing for its IPO, could command a valuation multiple higher than Maruti Suzuki, according to Nomura. The company’s expected market capitalisation ranges between Rs 1.5 trillion and Rs 1.7 trillion ($18 billion to $20 billion). The IPO is anticipated to launch in early November.




Reliance Industries: Reliance Retail’s fashion e-tailer, AJIO, has partnered with H&M to feature the brand’s products on its platform. This collaboration aims to enhance H&M’s online presence in India, offering over 10,000 styles across womenswear, menswear, kidswear, and home décor. 




Torrent Pharmaceuticals: The company has refuted claims from the Central Drug Standards Control Organisation (CDSCO) regarding its product, Shelcal 500, being labeled as Not of Standard Quality (NSQ). The company asserted that the seized sample was spurious and not manufactured by them, as the batch was traced to a different manufacturer. Torrent said it has implemented anti-counterfeit measures, including QR codes, to verify product authenticity.




Ola Electric: The company announced plans to open 10,000 sales and service outlets by the end of 2025, targeting expansion in smaller cities. The company has already onboarded 625 partners and aims to reach 1,000 by the festive season. Ola currently operates 800 company-owned stores and is looking to enhance its service network significantly, which aligns with its goal of boosting electric vehicle adoption across India.




Adani Green Energy: AGEL has completed a 50:50 joint venture with TotalEnergies, with TotalEnergies investing $444 million for a stake in AGEL’s solar projects in Gujarat. The partnership will focus on a portfolio of 1,150 MWac of solar energy projects.




Thermax: The company is accelerating its global expansion plans, aiming to double its presence in Southeast Asia, Africa, and the Middle East. Currently, 30 per cent of its business comes from international markets, and the company is focusing on sustainable solutions such as hydrogen and carbon capture. Thermax recently secured a significant order for gas-fired boilers in the UAE and is capitalizing on biomass opportunities in Africa.




Balmer Lawrie & Co: The company plans to invest Rs 700 crore to achieve a revenue target of Rs 6,000 crore by 2030. The investment will support diversification into ethanol production, establishing a free trade warehousing zone in Mumbai, and enhancing third-party logistics services. 




SpiceJet: The airline has cleared pending salaries for its employees from June to August following a Rs 3,000 crore capital raise through a Qualified Institutional Placement (QIP). This move comes as the airline works to improve its financial stability amidst ongoing challenges, including grounded aircraft due to financial constraints and maintenance issues.




Biocon: The company has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialise its GLP-1 products for diabetes and chronic weight management in select Middle Eastern countries. Under the agreement, Biocon will develop and manufacture the products, while Tabuk will handle marketing and registration. 




IDBI Bank: The bank has launched the Sugam Rinn Bhugtan Yojana, a special one-time settlement scheme aimed at retail borrowers with outstanding amounts between Rs 10 lakh and Rs 10 crore. The scheme targets non-performing assets (NPAs) and allows eligible borrowers to settle their dues without legal complications. With around Rs 2,300 crore in outstanding loans affected, the initiative seeks to resolve long-pending accounts and strengthen the bank’s financial standing, which reported a gross NPA ratio of 3.87 per cent in Q1FY25.




IndiGo: The airline has nominated Isidro Porqueras as its new Chief Operating Officer (COO), effective November 1, 2024, pending regulatory approvals. Porqueras, who joined as Chief of Transformation earlier this year, brings over 25 years of experience in the airline industry, including leadership roles at Volotea. 



Source link

Nandish Shah of HDFC Securities suggests 'Bull Spread' strategy on Nifty

Nandish Shah of HDFC Securities suggests 'Bull Spread' strategy on Nifty



Derivative Strategy


BULL SPREAD Strategy on NIFTY

Click here to connect with us on WhatsApp


1) Buy Nifty (03-Oct Expiry) 26200 Call at Rs 140 & simultaneously sell 26500 Call at Rs 40


Lot Size: 25




Cost of the strategy: Rs 100 (Rs 2,500 per strategy)

 


Maximum profit: Rs 5,000 If Nifty closes at or above Rs 26,500 on 03 Oct expiry.




Breakeven Point: Rs 26,300




Risk Reward Ratio: 1: 2




Approximately margin required: Rs 13,000


Rationale:


— Long rollover is seen in the Nifty Futures, where we have seen sharp rise in the open interest with Nifty rising by 0.81% to close at yet another new all time high.

 

 


— Short term trend of the Nifty remains bullish as it is placed above its 5, 11 and 20 day EMA.


— Momentum Indicators and Oscillators are in rising mode and placed above 60 on the weekly chart, indicating bullish trend.




— Amongst the NIFTY options, Put writing is seen at 26000-26200 levels.


(Disclaimer: Nandish Shah is a senior technical/derivative analyst at HDFC Securities. Views expressed are his own.)

First Published: Sep 27 2024 | 6:25 AM IST



Source link

Gulf Oil Lubricants India promoter sells 4% stake for over Rs 263 crore

Gulf Oil Lubricants India promoter sells 4% stake for over Rs 263 crore


| Image: Wikimedia Commons


Gulf Oil International Mauritius Inc, promoter of Gulf Oil Lubricants India, on Thursday divested a 4 per cent stake in the company for over Rs 263 crore through open market transactions.


According to the block deal data available on the BSE, Gulf Oil International Mauritius Inc. offloaded 19,50,000 shares, amounting to a 3.96 per cent stake in Gulf Oil Lubricants India.

Click here to connect with us on WhatsApp


The shares were disposed of at an average price of Rs 1,351 apiece, taking the transaction value to Rs 263.44 crore.


After the stake sale, Gulf Oil International Mauritius’ holding has come down to 67.8 per cent from 71.76 per cent.

 


UTI Mutual Fund (MF), ITI MF, Baroda BNP Paribas MF, JM Financial MF, Aditya Birla Sun Life Insurance, Axis Securities and Societe Generale were among the buyers of Gulf Oil Lubricants India’s shares.


Shares of Gulf Oil Lubricants India declined 4.88 per cent to close at Rs 1,370.95 apiece on the BSE.


In a separate transaction on the BSE, Cube Highways and Infrastructure II sold 1.16 crore units or 0.9 per cent unitholding in Cube Highways Trust (Cube InvIT) for a little over Rs 139 crore through an open market transaction.


Cube Highways Trust is one of India’s largest private-sector toll road operators.


The units were disposed of at an average price of Rs 120 per unit, taking the deal value to Rs 139.20 crore.


Singapore-based Cube Highways and Infrastructure III Pte Ltd is the sponsor of Cube InvIT.


Cube Highways Trust’s unit ended flat at Rs 120 per unit on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Sep 26 2024 | 11:33 PM IST



Source link

YouTube
Instagram
WhatsApp